Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Reflective Case-Based Oncology Collective™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma

Philippe Armand, MD, PhD; Sarah C. Rutherford, MD; Tycel J. Phillips, MD

Medical Crossfire®: Unpacking the Latest in Diagnostics and Decision Drivers for Follicular Lymphoma

Nicolas Palaskas, MD, FACC; Daniel Addison, MD; Eric H. Yang, MD, FACC, FASE; Lili Zhang, MD, FACC

Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Karen M. Winkfield, MD, PhD; Otis Brawley, MD; Ana Maria Lopez, MD, MPH, MACP, FRCP; Jamil Rivers

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

Reflective Case-Based Oncology Collective™: Translating Recent Evidence on CAR T Cell Therapy to the Real-World Management of Lymphoid Malignancies

Bradley J. Monk, MD, FACS, FACOG; Robert L. Coleman, MD, FACOG, FACS; Domenica Lorusso, MD, PhD; Ursula A. Matulonis, MD

Medical Crossfire®: How Are We Integrating Immune Checkpoint Inhibitors and Targeted Therapies to Personalize Therapy in Endometrial Cancer?

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Terry P. Mamounas, MD, MPH, FACS; Sara M. Tolaney, MD, MPH

Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Aditya Bardia, MD, MPH; Joyce O’Shaughnessy, MD; Mothaffar F. Rimawi, MD

Medical Crossfire®: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

Maria Dimou, MD, PhD; Matthew S. Davids, MD, MMSc; Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD; Joshua Richter, MD

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

Cancer Summaries and Commentaries: Report from Atlanta on Advancements in the Treatment of ITP

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

Clinical Consultations™: Evolving Paradigms for the Management of Chronic Kidney Disease and Cardiovascular Comorbidities

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Omid Hamid, MD; Jeffrey S. Weber, MD, PhD; Rodabe N. Amaria, MD; Ragini Kudchadkar, MD; Sapna Patel, MD

Community Practice Connections™: 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Oncology On-Call®: The Experts’ Take on How Sea Changes in GvHD Prophylaxis and Management Can Be Practically Implemented in Your Clinic

Oncology On-Call®: Advancing Care in SCLC with Novel Therapies

Emerging Therapies for Relapsed/Refractory Multiple Myeloma

Virtual Case Studies in Pustular Psoriasis: Refining Our Approaches to the Assessment of Our Patients

Burst Expert Illustrations & Commentaries™: A Clear Focus on Novel Formulations for the Management of Dry Eye Disease

Andre H. Goy, MD; Noopur Raje, MD; Bijal Shah, MD, MS

Community Practice Connections™: CAR T Preconference Workshop

Debu Tripathy, MD; Aditya Bardia, MD, MPH; Claudine Isaacs, MD; Tiffany A. Traina, MD

Community Practice Connections ™: Aligning the Data With Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Jorge E. Cortes, MD; Christopher R. Flowers, MD, MS, FASCO; Lori A. Leslie, MD; Sagar Lonial, MD, FACP

Community Practice Connections™: 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma 

Nikolai A. Podoltsev, MD, PhD; John Mascarenhas, MD

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

Amy E. DeZern, MD, MHS; Catherine Broome, MD;  Michele P. Lambert, MD, MTR

Community Practice Connections™: Hematology Workshop: Navigating Nonmalignant Diseases in Everyday Practice 

Vallerie V. Mclaughlin, MD; Richard N. Channick, MD

Expert Illustrations & Commentaries™: Finding the Best Path Forward in PAH Management – A Focus on NO-cGMP Signaling

Hossein Borghaei, DO, MS; Lyudmila Bazhenova, MD; Ferdinandos Skoulidis, MD, PhD

Expanding Innovation in NSCLC Through Biomarker Testing and Efforts to Target KRAS G12C

Manesh R. Patel, MD; Marc P. Bonaca, MD, MPH, FAHA, FACC; Jorge Antonio Gutierrez, MD; Amy W. Pollak, MD, MSc, FAHA

Expert Illustrations & Commentaries Live!™: Antithrombotic Approaches to Reduce the Risk of Secondary Events in CAD and PAD

Esen K. Akpek, MD; John D. Sheppard, MD, MMSc, FACS

Advances in™ Sjögren Syndrome-Related Dry Eye Disease: A Focus on Pathophysiology and Clinical Trials

Jenny McDade Despotovic, DO; Laura Dogan, RN, BSN, CPN; Caroline Piatek, MD; Jennifer Russell, A-G NP

Medical Crossfire®: What Role Does the Onco-Nurse Play in the Care and Management of Patients With ITP?

Jared Weiss, MD; Michael Pulley, MD, PhD; Beth Sandy, MSN, CRNP

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

R. Sharon Chinthrajah, MD; Carla M. Davis, MD; and Edwin H. Kim, MD, MS

The Future of Food Allergy: Novel Treatment Options on the Horizon

Kelley R. Branch, MD, MSc, FACC, FSCCT,Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC

Expert Illustrations & Commentaries™: Protecting Patients with CAD and PAD from Secondary Events with Effective Antithrombotic Strategies

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Expert Illustrations & Commentaries™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Medical Crossfire®: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care 

Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients with Relapsed/Refractory DLBCL

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

Aditya Bardia, MD, MPH, Adriana D. Corben, MD, Hope S. Rugo, MD, FASCO, Joseph A. Sparano, MD, FACP

Next Generation Sequencing Workshop™: Breast Cancer Edition

September 30, 2022: 8:00 AM – 5:00 PM ET

Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials 

ASCO Direct Highlights™ New York, NY

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Cases and Conversations™: Determining When and How to Integrate PCSK9 Inhibition into Practice

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Medical Crossfire®: Addressing the Top 10 Clinical Challenges in Melanoma

Placing New MPN Therapies into Context Through Illustrated Case Discussions

ASCO Direct Highlights™ - Charlotte

ASCO Direct Highlights™ - Dallas

ASCO Direct Highlights™ Nashville 2022

Understanding Emerging Options in MGD-Associated Dry Eye Disease: Preparing for an Updated Armamentarium

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

ASCO Direct Highlights™ - Dallas Copy

Victor M. Rivera, MD, FAAN; Robert K. Shin, MD; Mitzi Joi Williams, MD

Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations

Expert Illustrations & Commentaries™: Visualizing New Therapies in Uveitic Macular Edema – Understanding Impact With an Updated Armamentarium

Michael E. Wechsler, MD, MMSc; Wanda Phipatanakul, MD, MS

Alleviating Asthma Burden—Identifying and Managing Poorly Controlled Disease in Pediatric Patients

Julie R. Brahmer, MD, MSc, FASCO; Rogerio C. Lilenbaum, MD; Mark A. Socinski, MD; Everett E. Vokes, MD

Community Practice Connection™ 19th Annual Winter Lung Cancer Conference®

Immunotherapy Biomarkers and New Targets in Head and Neck Cancer

Advances in™: How Are Evolutions in DLBCL Reshaping Sequencing Considerations?

Joyce O’Shaughnessy MD; Heather L McArthur MD,  MPH; Hatem Soliman MD


Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Anthony Mato, MD, MSCE; Lindsey Roeker, MD; Chaitra Ujjani, MD

Conversations and Commentaries™: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice

Arshad M. Khanani MD, MA; Peter K. Kaiser, MD; Sophie J. Bakri, MD

Medical Crossfire®: The Role of Inflammation in the Treatment of Diabetic Macular Edema – Expert Insights and Case Considerations

Patrick I. Borgen, MD; Joshua A. Feinberg, MD; Gary Schwartz, MD

REEL Time:  Improving Recovery Times and Quality of Life With Postoperative Opioid-Sparing Strategies for Patients With Breast Cancer

Courtney DiNardo, MD, MSCE; Keith W. Pratz, MD

Oncology Consultations®: Utilizing Molecular Testing Technologies to Inform Treatment Decision-Making in Acute Myeloid Leukemia

Burst CME™: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 

William D. Chey, MD, FACG, AGAF, RFF; Bruce E. Sands, MD, MS

3rd Annual Virtual Medical Crossfire® in IBS and IBD

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD, MPH; Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Medical Crossfire®: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

Gary R. Lichtenstein, MD; Bruce E. Sands, MD, MS

Embracing Biosimilars in IBD: How Can We Leverage Them in Our Practice?

Inder Paul Singh, MD, MPH; Elizabeth Yeu, MD

Expert Illustrations & Commentaries™: Visualizing Optimal Astigmatism Management in Cataract Surgery

John D. Sheppard, MD, MMSc, FACS; Noam A. Cohen, MD, PhD; Michael Greenwood, MD; Rishi P. Singh, MD, FASRS; Inder Paul Singh, MD, MPH; Ivan J. Suñer, MD, MBA

(COPE Credit) Clinical Interchange™: Looking Out for Dry Eye Disease in Special Populations—DED Considerations in Glaucoma, Cataracts, Refractive Surgery, and Retinal Diseases

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It? 

(CME Credit) Clinical Interchange™: Looking Out for Dry Eye Disease in Special Populations—DED Considerations in Glaucoma, Cataracts, Refractive Surgery, and Retinal Diseases

Cancer Summaries and Commentaries™: Updates from Atlanta on the Treatment of MPNs

Benjamin Levy, MD; Melissa L. Johnson, MD; Joshua K. Sabari, MD; Helena Yu, MD

2021 Year in Review: Reflecting on Recent Evidence with an Eye to the Future of Lung Cancer Management

Jason Westin, MD, MS, FACP; Philippe Armand, MD, PhD; Lori A. Leslie, MD; Sonali M. Smith, MD; Pallawi Torka, MD

Bridging Clinical Gaps in B-Cell Lymphomas: Linking Novel Mechanisms to Advance New Treatment Strategies

8th Annual School of Gastrointestinal Oncology® (SOGO®)

Single-Agent PARP Inhibitors and Combination Therapies for Pancreatic Cancer

New York GU™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Hope S. Rugo, MD, FASCO; Sara M. Tolaney, MD, MPH

Clinical Vignette Series: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer

Loretta J. Nastoupil, MD; Gilles Salles, MD

Advances In™ Diffuse Large B-Cell Lymphoma: Integrating Recent Evidence into Practice

Oncology Consultations®: Bridging Multidisciplinary Approaches and Evolving Data for Immunotherapy for NSCLC in Curative Settings

Charu Aggarwal, MD, MPH; Jeffrey S. Weber, MD, PhD

Advances In™: Leveraging the Clinical Benefits of Immunotherapy In Cancer Through Newly Designed Immune Checkpoint Inhibitors

Expert Illustrations & Commentaries™: Harnessing the Power of SYK Inhibition to Reduce the Inflammatory Response in Patients Hospitalized With COVID

40th Annual Miami Breast Cancer Conference®

Jerald P. Radich, MD, Paolo Ghia, MD, PhD, Lori Muffly, MD, Mark Roschewski, MD, Sandy W. Wong, MD

Community Practice Connections ™: Adopting MRD Assessment for Hematologic Malignancies in Real-World Settings: Technique, Role, and Utilization to Improve Patient Outcomes

Heather A. Wakelee, MD; Megan E. Daly, MD; Brendon M. Stiles, MD

NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings

Richard K. Bogan, MD, FCCP, FAASM; Lynn Marie Trotti, MD, MSc

Advances in™ Sleep Medicine: New Opportunities to Effectively Manage Patients with Idiopathic Hypersomnia

The 5th Annual Advanced Practice Collaborative

27th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

3rd Annual International Congress on the Future of Women’s Health™

Advances In™: Next-Generation Sequencing Methodologies Across Breast Cancer

Robert Ferris, MD, PhD, Yelena Y. Janjigian, MD, John Timmerman, MD, Jeffrey Weber, MD, PhD

Community Practice Connections™: 6th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

The Role of Biosimilars in Crohn Disease and Ulcerative Colitis: Clinical Strategies to Assist Pharmacists in Practice

Evaluating the Utilization of Biosimilars in Oncology: Managed Care Considerations 

Classify the core concepts that drive the biosimilar approval process and identify how it differs from the approval of an originator biologic.

Continuing Education